Skip to main content
  • Shipping rates and free-shipping thresholds are shown in your selected market currency.
  • USD · $35 standard shipping below $199 · Free at $199 or more
  • Import duties included in every price — nothing extra to pay at delivery
  • Worldwide delivery with tracking on every order
Lenvima (Lenvatinib) 4mg Capsules product image 1
Thyroid Care

Lenvima (Lenvatinib) 4mg Capsules

Choose capsule quantity

Current price

$315.00For 10 capsules

Ready to order

SKU EM-LENVIMAL-3905-10CAP

No online payment is taken when you place the order.

Lenvima (Lenvatinib) 4mg Capsules—
$315.00

Buy Lenvima (Lenvatinib) 4 mg capsules online at Essential meds. Available in 5 pack sizes. Choose an option to see its price, and review the full details on the product page before ordering.

  • Free international shipping over $199
  • 100% authentic, genuine medicine
  • Tracked delivery across our service region
Checkout creates your order without an online payment charge.
After placing your order, review the confirmation page for your order number and next steps.

Product details

Overview, use & safety

Additional details

More about this product

Review the available overview, use, safety, and other product details.

6 sections
Overview

Lenvima 4 mg Capsules contain Lenvatinib, a targeted cancer therapy used in the treatment of advanced thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). It belongs to a class of medications known as tyrosine kinase inhibitors (TKIs), which block specific enzymes involved in the growth and spread of cancer cells. This 4 mg strength is often used alone or in combination with other strengths to achieve the prescribed daily dose.

Key Benefits
  • Slows or halts the growth of cancer cells in thyroid, kidney, and liver cancers
  • Improves progression-free survival in patients with advanced disease
  • Used in combination with other medications (e.g., pembrolizumab) for RCC
  • Oral administration offers convenience over injectable chemotherapy
  • Proven efficacy in radioiodine-refractory differentiated thyroid cancer (RR-DTC)
How to Use
  • Take Lenvima capsules orally with or without food, at the same time each day
  • Swallow the capsule whole with water; do not open or crush
  • Follow your oncologist’s instructions regarding dose combination (e.g., multiple strengths)
  • Adhere strictly to the prescribed schedule; do not change or skip doses
Dosage Information
  • The usual starting dose and schedule depend on cancer type and patient tolerance
  • For thyroid cancer: 24 mg once daily (can be achieved using combinations like 4 mg + 10 mg)
  • For RCC (with pembrolizumab): 20 mg once daily
  • For HCC (based on body weight): 8 mg or 12 mg once daily
  • Dose adjustments may be required for side effects or organ function changes
  • Your doctor may combine 4 mg capsules with other strengths to reach the exact required dose
Safety Information
  • Inform your doctor of any history of hypertension, liver/kidney disorders, bleeding issues, or heart disease
  • Monitor blood pressure, liver function, and ECGs regularly during treatment
  • Not recommended during pregnancy or breastfeeding
  • Use effective contraception during treatment and for at least 1 month after the last dose
  • Avoid grapefruit juice as it may interact with the drug’s metabolism
Possible Side Effects
  • Common and serious side effects may include:
  • High blood pressure (hypertension)
  • Fatigue, diarrhea, loss of appetite
  • Weight loss, nausea, vomiting
  • Protein in urine, joint or muscle pain
  • Serious: arterial thromboembolism, liver dysfunction, kidney impairment, QT prolongation, gastrointestinal perforation
  • Seek immediate medical attention for chest pain, vision changes, unusual bleeding, or severe abdominal pain.

Follow the product label and the advice of a qualified healthcare professional for product-specific use and safety questions.

Shown before you order

No online payment gateway